VARIPULSE Catheter System for Atrial Fibrillation
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Age
- 22 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 276 (estimated)
- Sponsor
- Biosense Webster, Inc. · Industry
This trial is looking for people with symptomatic paroxysmal atrial fibrillation. Participants will be using the VARIPULSE catheter system to help manage their condition over time.
You may be able to join if
- I have symptomatic paroxysmal atrial fibrillation.
- I cannot use or do not want at least one antiarrhythmic drug.
- I am willing and able to give consent.
- I can follow all testing and check-up requirements.
You may not be able to join if
- I have been diagnosed with persistent or long-standing persistent atrial fibrillation.
- I have had previous surgery or catheter ablation for atrial fibrillation.
- I have a significant medical problem that would prevent catheter ablation.
- I am currently in another clinical trial for a different device or drug.
- My life expectancy is less than 12 months.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Loading trial locations…